Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies [Phase 1, Phase 2]
Clinical trial update for CN202 in adults with locally advanced or metastatic solid tumors or hematologic malignancies (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors [Phase 1]
Phase 1 study of ramucirumab in pediatric patients with refractory solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients [Phase 2]
Phase 2 safety study of Oraxol (HM30181 + oral paclitaxel) in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: A Study of AK-01 (LY3295668) in Solid Tumors [Phase 1, Phase 2]
A two-phase clinical trial evaluating AK-01 (LY3295668) in solid tumors has completed phases 1 and 2 with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: ATG-008 Combined With Toripalimab in Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial updates for ATG-008 in combination with toripalimab in advanced solid tumors are in Phase 1 and Phase 2, with status not disc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]
Open-label Phase I/II study investigating manganese plus radiotherapy in patients with metastatic solid tumors or lymphoma; current status a…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer [Phase 1]
Phase 1 safety study of selinexor (KPT-330) in advanced or metastatic solid tumors has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients [Phase 1]
Phase 1/open-label pharmacokinetic study assessing interactions between tazemetostat and CYP enzymes and gastric pH in patients with B-cell …
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases [Phase 2]
Phase 2 trial evaluating apatinib combined with SHR-1210 as second-line therapy in solid tumors with liver metastases.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors. [NA]
Clinical trial comparing three tissue acquiring techniques during EUS-guided biopsies of solid tumors has been terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) [Phase 1]
Phase 1 study evaluating pembrolizumab monotherapy and combination therapy in advanced solid tumors and lung cancer; completed with results …
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors [Phase 2]
Phase 2 trial update for HX008, a recombinant human anti-PD-1 monoclonal antibody, in advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating Magrolimab (Hu5F9-G4) with cetuximab in solid tumors and advanced colorectal cancer completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation [Phase 1, Phase 2]
Clinical trial update for enasidenib (AG-221) in adults with advanced solid tumors, glioma, or angioimmunoblastic T-cell lymphoma harboring …
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial of ridaforolimus and vorinostat in advanced solid tumors or lymphoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas [Phase 1]
Phase 1 trial update for Sym022 (anti-LAG-3) in patients with advanced solid tumors or lymphomas has finished enrollment with results posted…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx [Phase 2]
A Phase 2 trial evaluating SBRT combined with PD-1/PD-L1 inhibiting therapy in advanced solid tumors after disease control on PD-1/PD-L1 the…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Tepotinib in Solid Tumors Harboring MET Alterations [Phase 2]
Phase 2 trial update for tepotinib in solid tumors with MET alterations, including MET exon 14 skipping and MET amplification.
-
CLINICAL_TRIALS trial_result · 2020-11-16Clinical Trial Update: Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients [Phase 1]
Phase 1 pharmacokinetic and safety study of niraparib in patients with normal or moderate hepatic impairment has completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors [Phase 1, Phase 2]
A study evaluating SHR2150 (TLR7 agonist) in combination with chemotherapy plus PD-1 or CD47 antibody for unresectable/metastatic solid tumo…
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors [Phase 2]
Phase 2 trial evaluating radiotherapy with irinotecan and apatinib followed by PD-1 antibody and apatinib for advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers. [Phase 1]
A Phase 1 study assessing safety, performance, and bioavailability of entrectinib in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update of enzastaurin in Chinese patients with advanced/metastatic solid tumors or lymphoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating topotecan plus sargramostim in adults with advanced cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma [Phase 1]
Phase 1 study of MLN2480 in relapsed/refractory solid tumors with dose expansion in metastatic melanoma has completed; results posted.